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A B S T R A C T
Photoallergic dermatoses are skin lesions following sun exposure, characterized by activation of immunological me-
chanisms, involving photosensitizers and photoallergens that can cause photosensibilization in some individuals. In
this group of disorders, photoallergic contact dermatitis should be accentuated. It manifests as contact allergic dermati-
tis on sun-exposed skin areas, following direct contact with photoallergens during UV exposure (predominantly UVA).
Under influence of light, photosensitizers get activated, followed by fusion with cutaneous proteins which renders them
to complete antigens, and consequential initiation of immunological mechanisms with resulting pathological skin le-
sions. The most common photoallergens are: sulfonamide antibiotics, phenothiazines, and halogenated salicylanilides.
Photoallergic dermatoses are comprised of several disorders, although the causative photoallergen remains unknown
(e.g. solar urticaria, polymorphous light eruption and hydroa vacciniforme). Solar urticaria is a rare, acute urticarial re-
action on both sun-exposed and covered skin areas, which appears soon after exposure to sun or artificial lighting. Poly-
morphous light eruption is a relatively common polymorphous skin eruption, which usually appears in spring. Its patho-
genesis is unknown, presumably photoallergic reaction. Hydroa vacciniforme is a rare photodermatosis of unknown
etiology, which usually presents in summer-time. It is characterized by vesicobullous eruptions, with residual nonesthe-
tic varioliform scarring.
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Introduction
Several skin reactions may follow sun exposure, medi-
ated by activation of hypersensitivity allergic mecha-
nisms1,2. We often hear of individuals »allergic to sun«,
referring to the family of photodermatoses. This group of
disorders comprises skin lesions following UV radiation
doses that would normally not cause photosensibilization
in healthy individuals. The most common are primary
photodermatoses, characterized by skin photosensibili-
zation with no evidence of any other underlying derma-
tosis, while secondary photodermatoses are associated
with underlying conditions, such as porphyria, lupus
erythematosus, or xeroderma pigmentosum. Primary pho-
todermatoses are traditionally comprised of idiopathic
photosensitivity forms, together with a group of reac-
tions associated with known toxic or allergic triggers,
while the third group of primary photodermatoses con-
sists of persistent light reactions1. Idiopathic photoder-
matoses include solar urticaria, polymorphic light erup-
tion, hydroa vacciniformis and actinic prurigo, charac-
terized by activation of immunological mechanisms. Pho-
todermatoses with known triggers are: photoallergic con-
tact dermatitis, systemic photoallergic dermatitis, and
phototoxic reaction; the former two represent delayed
hypersensitivity allergic reactions, while the latter has
non-immunological pathogenesis. The third group of pri-
mary photodermatoses, also known as chronic actinic
dermatitis, encompasses persistent light reaction, actinic
reticuloid, photosensitive eczema, chronic photosensitive
dermatitis, and photoaggravated atopic dermatitis. The
family of chronic actinic dermatitides is partially charac-
terized by activation of allergic mechanisms, although
their etiology mostly remains unknown (some of them
are idiopathic, some have known triggers, but all of them
have chronic course)1,2.
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Solar Urticaria (Light Urticaria,
Photoallergic Urticaria)
Solar urticaria is a rare, acute urticarial reaction, ap-
pearing within minutes following exposure to sun or arti-
ficial lighting, primarily affecting elderly1,3. A wide vari-
ety of wavelengths, including the most common UVA,
UVB, UVC spectrum and visible light may provoke the
condition. The radiation is absorbed by an endogenous
chromophore, thus producing a new photoallergen, which
elicits a primary IgE-mediated immune response to the
mast cell-bound antigen. The subsequent exposure to the
same radiation source may produce additional photo-
allergen quantities, which bind mast cells and cause urti-
caria. At present, solar urticaria is categorized as type I,
with photoallergens unique to the patient, or type II,
where the patient produces antibodies against normal
components of the irradiated skin1. Solar urticaria ap-
pears within minutes following exposure to sun or artifi-
cial lighting, and is characterized by hives, pruritus and
erythema on both sun-exposed and covered skin areas.
The disease often follows a chronic course, persisting for
several years, with minor tendency towards spontaneous
regression. Clinical presentation of solar urticaria may
resemble erythropoietic protoporphyria, and occasion-
ally other forms of urticaria1,3. Phototesting can be per-
formed for diagnostic purposes; hives develop within
minutes of irradiation. The action spectrum (AS) (neces-
sary for initiation of the clinical reaction) also has to be
defined for the given patient (individuals report reactiv-
ity to UVA, UVB, UVC, and visible light), as well as the
minimal urticarial dose (MUD). Long-acting antihista-
mines can be administered prior to sun exposure, al-
though often without clear benefit. Phototherapy is the
treatment of choice. Repeated UV radiation or visible
light exposure results in temporary clinical improvement
due to mast cell exhaustion and prolonged re-synthesis of
their mediators. UV radiation and visible light of the ap-
propriate AS are used to provide temporary clinical bene-
fit, so PUVA therapy has become the treatment of choice.
It is recommended, during this lull, to initiate PUVA
therapy, sometimes in conjunction with systemic cortico-
steroid therapy, and to continue PUVA therapy through-
out the summertime1,3. Severely affected patients can be
treated with azathioprine and plasmapheresis.
Polymorphic Light Eruption
(Polymorphous Light Eruption,
Summer Prurigo, Summer Eruption,
Prurigo Aestivalis, Eczema Solare)
Polymorphic light eruption (PMLE) is a common idio-
pathic photodermatosis, with mandatory monomorphous
presentation for the given patient, but a wide range of
clinical features among patients, as its name suggests1,4.
It is the most common form of idiopathic photoderma-
tosis, and the second most common skin reaction follow-
ing sun exposure, resulting from sun burns. As esti-
mated, at least 10–20% of individuals are affected, which
is often described as toxic sun reaction or sun allergy. Eu-
ropean population shows female predominance, with es-
timates ranging as high as 9:1, with similar ratio esti-
mates for the US. The PMLE of Native Americans is de-
scribed today as actinic prurigo, characterized by clinical
features of both PMLE and atopic dermatitis. Patients
with PMLE may often have stigmata of atopic dermati-
tis, and a positive family history of atopy. The etiology of
PMLE is unknown; the reaction is probably type IV or
delayed hypersensitivity reaction to an unknown aller-
gen. The AS is usually in the UVA spectrum, but may fall
into the UVB, although some patients react to both
wavelengths. The majority of patients notice skin lesions
during spring or early summer, which resolve spontane-
ously. Nowadays, with a massive tourist migration to
sunny regions during the winter, PMLE has become a
year-round problem1,4. Skin lesions appear hours to days
following UV radiation and are presented on sun-ex-
posed areas. Irregular erythema is seen initially, usually
associated with pruritus. The most commonly affected
sites are the face, lateral neck regions, the upper lateral
aspects of arms, and dorsal sides of hands. The most com-
mon variant is a papular or a papulovesicular form, usu-
ally appearing on the décolletage, although other mor-
phologic variants of PMLE may also appear, such as
hemorrhagic lesions, plaques, erythema multiforme-like
lesions, insect bite-like reactions, or vesiculobullous le-
sions. Individual lesions often coalesce. None of the le-
sions resemble dermatitis, although excoriations, weep-
ing, crusting and scaring may be seen in patients with
simultaneous atopic dermatitis. PMLE may resemble
numerous dermatoses due to the various morphologic
patterns. Papulovesicular form may mimic atopic derma-
titis, photoallergic dermatitis, prurigo simplex and even
hemorrhagic leukocytoclastic vasculitis. The plaque form
can resemble solar urticaria, erythropoietic protopor-
phyria, erythema multiforme, or lupus erythematosus1,4.
Juvenile spring eruption is a variant of PMLE affecting
primarily boys or young men during early spring, with
predilection for ear helices, hands, and nose. The lesions
resolve spontaneously after discontinuation of sun expo-
sure. However, the reaction is very likely to reoccur fol-
lowing re-exposure. This is a chronic disease; according
to long-lasting studies that followed patients for over
30-year periods, about half of the patients showed im-
provement, 25% were cured, while 25% deteriorated dur-
ing the course of disease. Lesions can be easily provoked
by phototesting, irradiation of predilection areas with
high doses of UVA, UVB, or both for 3 consecutive days.
Most patients react to UVA or the combination irradia-
tion; only several patients react only to UVB. Topical
corticosteroids are usually administered. Sunscreens with
good UVA coverage, appropriate protective clothing, and
gradual sun exposure may serve as important prophylaxis.
Phototherapy is regarded the most effective prophy-
laxis; it has to be initiated 4–6 weeks prior to UVA or
UVB radiation exposure, as required by the action spe-
ctrum1,5,6. PUVA causes even better improvement and
probably represents the treatment of choice for severely
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affected patients. Extremely sensitive patients may re-
quire simultaneous use of systemic corticosteroids and
PUVA. A variety of systemic medications have been
tested, including b-carotene, chloroquine, nicotinamide,
antihistamines, and calcium supplements, unfortunately
with disappointing results. Systemic corticosteroids can
sometimes be used, with dose reduction over the course
of disease.
Hydroa Vacciniformis
Hydroa vacciniformis is an extremely rare type of
photosensitivity. Its etiology is largely unknown, although
UVA appears to be responsible1,7. Its usual onset is dur-
ing the first years of life; girls are more often affected
than boys. Erythematous papules and plaques develop
on photoexposed areas, such as nose, cheeks, tips of the
ears, and dorsa of hands, usually in the spring. Skin le-
sions evolve into blisters that are often hemorrhagic,
they acquire dark crusts, and tend to heal leaving resid-
ual depressed varioliform scars, as the name itself sug-
gests. In addition, postinflammatory hypo- and hyper-
pigmentation may occur. In severe cases, it can result in
mutilation of ears, nose and distal phalanges. Clinical
presentation of hydroa vacciniformis may resemble ery-
thropoietic protoporphyria or congenital erythropoietic
porphyria, since both are characterized by early photo-
sensitivity and scarring. In the most severe cases, cor-
neal lesions may appear, thus leading to impaired vision.
The attacks tend to reoccur each spring, but often dimin-
ish as the patient reaches adolescence. Repeated provo-
cation of the back area with large doses of UVA may re-
sult in typical hemorrhagic lesions. There is no adequate
therapy, except for sunlight avoidance. Broad spectrum
UVB and UVA sunscreens ought to be used; patients
should also wear sunglasses with a high degree of UVA
protection. If lesions continue to progress, systemic corti-
costeroids should be administered. PUVA-induced ame-
lioration can be tried, although patients are very sensi-
tive and may not tolerate the induction1,7.
Actinic Prurigo
Actinic prurigo is an extremely rare condition; most
cases are sporadic. It usually appears before the age of 10
in the European population1,8. The condition is predomi-
nantly seen among Native Americans (the terms familial
actinic prurigo or hereditary polymorphic light eruption
are often used), and in Central and South America, espe-
cially in mestizos (mixed Spanish and Native American
origin). Some authors believe the disease in Native Ame-
ricans is not identical to the rare European entity, while
others think they represent varying features in different
racial groups of Americans. Actinic prurigo shows stig-
mata of atopic dermatitis. The mechanism of photo-
sensitivity remains unclear. Different HLA predilections
have been found. The AS for actinic prurigo is primarily
UVA, although some patients are also responsive to the
UVB spectrum1,8. Clinically, actinic prurigo represents
an overlap between atopic dermatitis and PMLE. Char-
acteristic prurigo lesions are uncommon; hence the name
of the disease is rather inadequate. Its course is seasonal,
with the onset in spring, and occasional regression in the
late summer. The very characteristic feature is the pres-
ence of exudative cheilitis with predilection for the lower
lip. Erythematous, edematous plaques tend to become
excoriated and crusted. They affect cheeks, neck, ears,
arms, and hands, and are associated with pruritus. Ini-
tially, lesions are limited to sun-exposed areas, with some
signs of remission or involvement of non-exposed areas
later on, in the off-season. Actinic prurigo may improve
in adolescence, yet some individuals develop disease in
adulthood. Considering low incidence in Europeans, clin-
ical features of dermatitis with tendency for development
of prurigo-like nodules, cheilitis, and overlap with light-
-sensitive atopic dermatitis and PMLE may suggest the
diagnosis. The mainstay of therapy is topical, and in se-
vere cases, systemic corticosteroid therapy. While b-caro-
tene is not effective, thalidomide seems to be useful un-
der appropriate control. Although experience in photo-
therapy application is limited, UVA or PUVA therapy
seem to be beneficial1,8.
Photodermatoses Caused
By Exogenous Sensitizers
Such reactions can be divided into phototoxic and
photoallergic reactions. According to the etiology, photo-
allergic reactions fulfill all criteria for allergic reactions,
while phototoxic reactions have non-immunological eti-
ology. Phototoxic reactions are more common than pho-
toallergic reactions.
Photoallergic Dermatitis
Photoallergic dermatitis is a cutaneous reaction fol-
lowing photoallergen and UVA exposure, requiring prior
exposure to the allergen1,9,10. The photosensitizing sub-
stance can be applied locally or entered systemically. The
AS for photoallergic dermatitis is primarily UVA, al-
though in rare cases, as with sulfonamides and diphen-
hydramine, it lies within the UVB spectrum. Photo-
allergic reactions are significantly less common than
phototoxic reactions; their frequency is unknown. Men
are more likely to have photoallergic reactions than
women. Generally, drug-induced photosensitivity reac-
tions can occur in individuals of any age1,9,10. Photo-
allergic reactions resemble allergic contact dermatitis
and cell-mediated immune responses to a photo-acti-
vated compound and typically develop in sensitized indi-
viduals 24–48 hours post-exposure10. Previous exposure
to the allergen is required and only small percentage of
exposed individuals develops immune response and re-
sulting clinical symptoms. Once the patient becomes sen-
sitized, any method of exposure may subsequently lead
to overt disease. The interaction between the potential
allergen, the skin, and UV radiation produces a modified
substance, usually a hapten that binds to protein carriers
in the skin and thereby forms a complete antigen. Spe-
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cifically, Langerhans cells (LCs) and other antigen-pre-
senting cells take up the photoallergen and migrate to re-
gional lymph nodes where they present it to T cells,
which express antigen-specific receptors. Subsequent T
cell activation, proliferation, and migration back to the
site of photoallergen deposition, result in inflammatory
skin response10. Many substances are capable of causing
both phototoxic and photoallergic reactions. The most
common photoallergic medications include neuroleptic
drugs such as phenothiazines (chlorpromazine, fluphe-
nazine, pherazine, perphenazine, thioridazine); antifun-
gals (itraconazole); anti-inflammatory drugs (NSAIDs)
such as ketoprofen; diuretics such as hydrochlorothiazide;
hypoglycemics such as sulfonylureas (glipizide, glybu-
ride); sunscreens, such as para-aminobenzoic acid (PABA),
cinnamates, benzophenones, salicylates; fragrances, such
as musk ambrette, 6-methylcoumarin and others, such
as 5-FU, quinidine, dapsone etc10. Topical photoallergic
substances are: halogenated salicylanilides (TCSA, TBSA),
hexachlorophene, bithionol, musk ambrette, PABA and
related compounds, benzophenones, methoxycinnama-
tes, parsol 1789 (sunscreen cream), cyclohexanol etc. It
has been noted that halogenated salicylanilides used in
antibacterial soaps in the 1960s and early 1970s had
caused an epidemic of photoallergic dermatitis and also
led to many cases of persistent or chronic reactions to
light. Since they have been revoked from the market, the
most common topical photosensitizers nowadays are sun-
screens1,9,10. Skin lesions in photoallergic contact derma-
titis are pruritic and limited to sun-exposed areas, where
photoallergen has been applied. Generally, eczema usu-
ally appears when a photoallergen is applied topically,
but if a photoallergen is administered systemically, it re-
sults in skin drug reactions. The reaction usually mani-
fests as a pruritic eczematous eruption with erythema
and vesicles in the acute phase, while chronic exposure
results in erythema, lichenification and scaling. Hyper-
pigmentation is not a feature of photoallergic reactions10.
If the diagnosis is not made and exposure persists, it will
result in chronic photoallergic dermatitis accompanied
by lichenification, also lesions may progress to nonirra-
diated areas1,9,10. Occasionally, in case of more subtle ex-
posure, for example, many photosensitizers are present
in animal food products; farmers may develop reaction
on photoexposed areas. In winter months or with mini-
mal sun exposure, skin lesions may be trivial and the pa-
tient simply complains of pruritus or minor erythema.
When photoallergic medication is taken, the reaction be-
comes systemic in its nature. The clinical reaction corre-
sponds to photoallergic contact dermatitis, although it is
usually more diffuse and uniform on sun-exposed areas,
considering that topical application of medications often
skips areas can be applied less abundantly. Photoallergic
reactions are sometimes identical to phototoxic reac-
tions, but systemic photoallergic reaction is more diffuse.
Severe atopic dermatitis, especially if photoaggravated,
may also be very similar. Photopatch testing is the proper
way to identify photoallergic contact dermatitis, photo-
toxic dermatitis, and allergic contact dermatitis11. Avoid-
ance of the allergen and application of UVA sunscreens
and topical corticosteroids are the mainstays of therapy.
Also avoidance of UV radiation is essential for protection
of skin sun damages and developing skin malignant
tumors12,13.
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ALERGIJSKE REAKCIJE PREOSJETLJIVOSTI KO@E PRI IZLAGANJU SUNCU
S A @ E T A K
Fotoalergijske dermatoze obuhva}aju promjene ko`e kod kojih se pri izlaganju suncu aktiviraju imunolo{ki meha-
nizmi, koji uklju~uju senzibilizatore i fotoalergene koji uzrokuju fotosenzibilizaciju samo u nekih osoba. U toj skupini se
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isti~e dermatitis e contactu photoallergica koji se o~ituju slikom kontaktnoga alergijskog dermatitisa na svjetlu eksponi-
ranim dijelovima ko`e, a nastaje nakon izravna kontakta s fotoalergenom pri obasjavanju UV svjetlom (obi~no UVA).
Pod utjecajem svjetla fotosenzibilizator se aktivira, spaja se s proteinima ko`e i postaje potpuni antigen, nakon ~ega
slijedi uklju~enje imunolo{kih mehanizama i pojava patolo{kih promjena na ko`i. Naj~e{}i fotoalergeni su sulfonamidi,
fenotiazin i halogenirani salicilanilidi. Neke bolesti ubrajaju se u fotoalergijske dermatoze, iako uzro~ni fotoalergen nije
poznat (npr. urticaria solaris, polymorphous light eruption (prurigo aestivalis), hydroa vacciniforme). Urticaria solaris
je rijetka akutna urtikarijska reakcija koja se pojavljuje ubrzo nakon izlaganja sun~evim zrakama ili umjetnom svjetlu,
a smje{tena je na fotoeksponiranim i pokrivenim dijelovima ko`e. Polymorphous light eruption je razmjerno ~esta eru-
pcija na ko`i polimorfnog izgleda, a obi~no se pojavljuje u prolje}e. Nepoznate je patogeneze, a vjerojatno je rije~ o
fotoalergijskoj reakciji. Hydroa vacciniforme je rijetka fotodermatoza nepoznate etiologije koja se pojavljuje ljeti, a ispo-
ljava se vezikulobuloznom erupcijom, nakon koje preostaju neestetske varioliformne brazgotine.
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